Search results for "HERO"

showing 10 items of 1331 documents

Therapy with non-invasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype.

2009

Patients with obstructive sleep apnoea are at increased risk of atherosclerotic morbidity and mortality. Abnormalities in lipid metabolism that occur in response to chronic intermittent hypoxia in patients with sleep-disordered breathing may increase the cardiovascular risk in an already susceptible population. Atherogenic lipoprotein phenotype and small, dense LDL have an independent predictive role for future cardio- and cerebro-vascular events in patients with the metabolic syndrome. Therefore, testing the hypothesis that therapy of obstructive sleep apnoea may reduce atherogenic lipoprotein phenotype might have significant clinical implications. We suggest that abolition of obstructive …

medicine.medical_specialtyLipoproteinsmedicine.medical_treatmentmedicine.disease_causeInternal medicinemedicineHumansContinuous positive airway pressureOxygen saturation (medicine)Sleep Apnea Obstructivebusiness.industryobstructive sleep apnoea Atherogenic lipoproteinthe metabolic syndrome cardiovascular riskLipid metabolismGeneral MedicineAtherosclerosismedicine.diseaseRespiration ArtificialSleep in non-human animalsEndocrinologyCirculatory systemBreathingCardiologyMetabolic syndromebusinessaterosclerosiOxidative stress
researchProduct

El papel de la dislipemia aterogénica en las guías de práctica clínica.

2016

Background and objective Atherogenic dyslipidaemia is underdiagnosed, undertreated, and under-controlled. The aim of the present study was to assess the positioning of clinical guidelines as regards atherogenic dyslipidaemia. Material and method The major clinical guidelines of scientific societies or official agencies issued between January 1, 2012 and March 31, 2015 were collected from the MEDLINE database. High-density lipoprotein (HDL) cholesterol, triglycerides, atherogenic dyslipidaemia, non-HDL cholesterol, and apolipoprotein (apo) B were gathered from the 10 selected guidelines, and it was assessed whether these parameters were considered a cardiovascular risk factor, a therapeutic …

medicine.medical_specialtyLow HDL-cholesterolendocrine system diseasesApolipoprotein BNice030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCardiovascular preventionInternal medicinemental disordersmedicinePharmacology (medical)cardiovascular diseases030212 general & internal medicineRisk factorcomputer.programming_languagebiologybusiness.industryCholesterolnutritional and metabolic diseasesClinical Practicechemistrybiology.proteinlipids (amino acids peptides and proteins)Atherogenic dyslipidaemia Cardiovascular prevention Cholesterol Colesterol Dislipemia aterogénica Guías de práctica clínica Lipids Lípidos Practice guidelines Prevención cardiovascular Triglicéridos TriglyceridesCardiology and Cardiovascular MedicinebusinesscomputerLipoprotein
researchProduct

OP0090 THE OCCURRENCE OF SUBCLINICAL AND CLINICAL ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS, RESULTS FROM THE 3-YEAR, MULTICENTER, PROSPECTIVE, OBSERVA…

2019

Background The systemic inflammatory process and the “traditional” cardiovascular (CV) risk factors could synergize the enhancement of CV burden in rheumatoid arthritis (RA) [1]. Objectives To assess the occurrence and the predictive factors of subclinical and clinical atherosclerosis in patients with RA. Methods During 2015, consecutive patients, admitted to Italian Rheumatology Units, were assessed in GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) cohort [2]. After that, patients were followed-up in a 3-year, prospective, observational study, assessing the occurrence of subclinical (carotid and/or peripheral arteries atherosclerotic lesions detected by ultrasou…

medicine.medical_specialtyLow dosagebusiness.industryviruseseducationmedicine.diseaseInternal medicineSubclinical atherosclerosisRheumatoid arthritisCohortUltrasound imagingmedicineObservational studyIn patientbusinessSubclinical infectionOral Presentations
researchProduct

Efficacia di Buprenorfina/Naloxone nel trattamento delle tossicodipendenze: monitoraggio dei pazienti in terapia presso il Ser.T. di Marsala, ASL n. …

2018

Il lavoro sperimentale è stato eseguito nel periodo gennaio 2016-marzo 2017, presso il Ser.T. di Marsala dell’ASL n. 9 di Trapani, sotto la guida del Dott. Gaetano Gurgone e del Prof. Fabio Venturella, lavoro in cui sono stati altresì analizzati i dati relativi agli ultimi cinque anni. Il compito prevalente del Ser.T. è l’assessment, inteso come processo di raccolta, integrazione ed interpretazione delle informazioni.Si esplica attraverso: la diagnosi, la cura, la riabilitazione. Questo lavoro vuole essere quindi il resoconto di 15 mesi di osservazione su pazienti trattati con Buprenorfina/Naloxone,operando un confronto con pazienti trattati con il Metadone.Il campione è costituito da 32 so…

medicine.medical_specialtyMethadone hydrochloridebusiness.industryCravingMental activityWorld healthHeroinBuprenorfina Metadone NaloxoneNaloxonemental disordersSettore BIO/14 - FarmacologiaMedicinemedicine.symptombusinessPsychiatrymedicine.drug
researchProduct

Myocardial infarction with non-obstructive coronary arteries (MINOCA): Intracoronary imaging-based diagnosis and management.

2021

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is defined by clinical evidence of myocardial infarction (MI) with normal or near-normal coronary arteries on angiography. This condition is present in about 5% to 25% of patients presenting with acute coronary syndromes. MINOCA is a working diagnosis. Current guidelines and consensus recommend identification of underlying causes of MINOCA in order to optimize treatment, improve prognosis, and promote prevention of recurrent myocardial infarction. An accurate evaluation of patient history, symptoms and use of invasive and non-invasive imaging should lead to identification of epicardial or microvascular causes of MINOCA an…

medicine.medical_specialtyMyocarditisMyocardial InfarctionContext (language use)Coronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyCoronary artery disease03 medical and health sciences0302 clinical medicineMyocardial infarction with non-obstructive coronary arterieRisk FactorsInternal medicineIntravascular ultrasoundmedicineHumans030212 general & internal medicineMyocardial infarctionmedicine.diagnostic_testOptical coherence tomographybusiness.industryTakotsubo syndrome.Intracoronary imagingmedicine.diseaseCoronary VesselsPlaque AtheroscleroticPulmonary embolismCoronary arteriesmedicine.anatomical_structureAngiographyCardiologyIntravascular ultrasoundCardiology and Cardiovascular MedicinebusinessJournal of cardiology
researchProduct

Tissue characterization comparison of culprit lesions between stable coronary disease and ST elevation myocardial infarction patients

2013

medicine.medical_specialtyNecrosisbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionTissue characterizationCoronary diseasemedicine.diseaseCulpritAtheromaSt elevation myocardial infarctionInternal medicineFactor V LeidenmedicineCardiologyRadiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Bisphosphonates and atherosclerosis: why?

2005

The increasing knowledge on bone calcification processes has revealed some similarities with vascular tissue, where calcifications of arteries and cardiac valves contribute to several cardiovascular problems, such as heart failure, systolic hypertension, and myocardial and peripheral ischemic disease. Bisphosphonates have been used extensively for over two decades for the treatment of diseases associated with excessive bone resorption, i.e., osteoporosis, osteolytic bone metastasis, hypercalcemia and Paget’s disease, by blocking osteoclastic function. Etidronate, pamidronate and clodronate has been shown to inhibit the development of experimental atherosclerosis, and proposed mechanisms fo…

medicine.medical_specialtyOsteoporosisMevalonic AcidApoptosisDisease030204 cardiovascular system & hematologyBone resorption03 medical and health sciences0302 clinical medicineRheumatologyCalcinosisInternal medicinemedicineHumansBone ResorptionFoam cell030203 arthritis & rheumatologyDiphosphonatesMolecular Structurebusiness.industryMacrophagesBone metastasisCalcinosismedicine.diseaseAtherosclerosisArterial calcificationEndocrinologyCholesterolHeart failureCancer researchbusinessLupus
researchProduct

Cardiovascular risk and events in polycystic ovary syndrome

2009

Young women with polycystic ovary syndrome (PCOS) present a high risk for cardiovascular disease because of the presence of abdominal obesity, insulin resistance and androgen excess. In addition, they present with endothelial dysfunction and early signs of atherosclerosis (increased carotid intima-media thickness and increased coronary calcium). However, the evidence of increased cardiovascular events during the postmenopausal age is relatively small, although some recent studies have indicated a slight increase in the severity of cardiovascular disease in women who had PCOS during their fertile age. The discrepancy between cardiovascular risk in young age and postmenopausal cardiovascular …

medicine.medical_specialtyPCOS Cardiovascular risk myocardial infarction stroke atherosclerosisSettore MED/09 - Medicina InternaDiseaseAndrogen ExcessSeverity of Illness IndexSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsInternal medicinePrevalencemedicineHumansEndothelial dysfunctionAbdominal obesityEvidence-Based Medicinebusiness.industryHyperandrogenismObstetrics and GynecologyGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryPostmenopauseEndocrinologyPremenopauseCardiovascular DiseasesFemalemedicine.symptombusinessDyslipidemiaPolycystic Ovary SyndromeClimacteric
researchProduct

Atherosclerosis, inflammation and Chlamydia pneumoniae

2009

Coronary heart disease is the single most common cause of illness and death in the developed world. Coronary atherosclerosis is by far the most frequent cause of ischemic heart disease, and plaque disruption with superimposed thrombosis is the main cause of the acute coronary syndromes of unstable angina, myocardial infarction, and sudden death. Atherosclerosis is the result of a complex interaction between blood elements, disturbed flow, and vessel wall abnormality, involving several pathological processes: inflammation, with increased endothelial permeability, endothelial activation, and monocyte recruitment; growth, with smooth muscle cell proliferation, migration, and matrix synthesis; …

medicine.medical_specialtyPathologyATHEROSCLEROSIS INFECTIONUnstable anginabusiness.industryInflammationChlamydia Coronary atherosclerosis Coronary heart disease PhlogosisReviewmedicine.diseaseSudden deathThrombosisEndothelial activationInternal medicinemedicineCardiologyMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary atherosclerosisCalcification
researchProduct

Orthopantomography contribution to prevent isquemic stroke.

2014

Objectives: The ortopantomography (OPG) can be a valuable way for an early detection of calcified atheroma plaques, thus contributing for a preliminary stroke risk evaluation. The study looks for the existence of calcified atheroma plates through the use of OPG, comparing the results with the stenosis percentage found through eco-doppler. It has been analyzed the correlation of the number of years as a smoker, arterial hypertension and body mass index, against the risk of having calcified atheroma plaques. Study Design: Observational, transversal and prospective study with 84 patients from the Dental Center of Hospital Particular de Lisboa. First the patients answered to an inquiry and them…

medicine.medical_specialtyPathologyIsquèmia cerebralOrthopantomographyEarly detectionOdontologíaInternal medicineCarotid atheromamedicinecardiovascular diseasesProspective cohort studyGeneral DentistryStrokeArteritis de cèl·lules gegantsGiant cell arteritisCarotid diseaseOral Medicine and Pathologybusiness.industryResearchDental radiologyCerebral ischemiamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludStrokeStenosisAtheromaCalcified atheromaUNESCO::CIENCIAS MÉDICASCardiologycardiovascular systemCalcified atheromabusinessRadiologia dentalBody mass indexJournal of clinical and experimental dentistry
researchProduct